|
|
LSBC MEMBER NEWS ANNOUNCEMENTS
|
As a member benefit, LifeSciences BC publishes all our member news releases as we receive them. If you are a member and would like to have your news release published in
BioLinks, send them along to Susan Ogilvie at
sogilvie@lifesciencesbc.ca . Please include you company logo and a point of contact in the release.
Our BioLInks data shows us that we have an open rate of 39% with our member news getting the highest click - open rate. With a subscriber circulation of 4000+ readers, the data tells us the member news is a valuable read for our subscribers! So please, keep us up to date with your news - we all enjoy hearing about it!
|
|
President and CEO, LifeSciences BC
Wendy Hurlburt
|
|
Hope everyone is starting to enjoy some of our nice summer weather.
At LifeSciences BC, we have been engaging in and representing the BC Life Sciences sector in many global virtual conferences. ( A silver lining of the virtual world that we are currently living in). It has been amazing to see how, leveraging virtual tools, inter-connectivity and collaborations have continued and, in some cases, grown. While attending the conferences, we have had the opportunity to represent and promote the BC Life Sciences sector, while learning about the innovation and scientific advancements that are being pursued.
This week, LifeSciences BC attended the One Nucleus (the Cambridge-London Life Sciences Association)
ON Helix Conference
that was streamed live from the United Kingdom. The conference theme ‘
Transforming New Medicine Discovery’
, focused on understanding the impact of new science and the challenges faced in translating them in new healthcare products. We met and connected with a wide-range of delegates including representatives from Alderely Park (the UK’s largest single site life science campus), Celerion and other companies that were keen to find out more about the sector in British Columbia. We are really pleased to see the interest in our community overseas and will be working on ways in which we can maximize opportunities from these networks, to our membership.
Regarding COVID 19, there is still much information to circulate to our members, as both provincial and federal responses are updated regularly. Here is a helpful link that identifies all the federal sources on
COVID 19
members might find useful. Please do not hesitate to reach out if you have any questions.
|
|
|
|
LivaNova Announces Publication Detailing the Design of the RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression
|
London, July 7, 2020 – LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a publication in Contemporary Clinical Trials1, which details the design for “A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression” or the RECOVER clinical study.
READ MORE
|
|
|
|
BOLD-100 Demonstrates Nanomolar Range Inhibition of Live COVID-19 In Vitro
|
Vancouver, BC – July 15, 2020 – Bold Therapeutics, a clinical-stage biopharmaceutical company, has in vitro data showing that its lead clinical-stage therapeutic, BOLD-100, successfully inhibits live SARS CoV-2 (COVID-19) within a therapeutic range.
READ MORE
|
|
|
|
Canadian Consortium Increases Access to Cancer Testing and Treatment in Response to COVID-19
|
VANCOUVER, BRITISH COLUMBIA, July 15, 2020 – A consortium led by Vancouver-based
Canexia Health
(formerly Contextual Genomics) will enable access to critical testing and treat
ment
options for Canadian cancer patients during the COVID-19 pandemic. Supported by the Digital Technology Supercluster, the CAD $2,590,000 initiative, named Project ACTT – Access to Cancer Testing & Treatment.
...
READ MORE
|
|
|
|
LivaNova Announces Commercial Launch of Perceval Plus Aortic Heart Valve in Europe
|
LONDON–(BUSINESS WIRE)–Jul. 16, 2020–LivaNova PLC (NASDAQ:LIVN) a market-leading medical technology and innovation company, today announced that the advanced Perceval
®
Plus sutureless surgical aortic heart valve is now available for commercial release in Europe, having successfully completed a one-year limited launch with initial real-world clinical data gathering.
READ MORE
|
|
|
|
CDL Health and adMare BioInnovations partner to accelerate the commercialization of health innovations
|
Vancouver and Montreal, Canada – July 16, 2020: Creative Destruction Lab (CDL), founded by Ajay Agrawal at University of Toronto’s Rotman School of Management, and adMare BioInnovations, Canada’s global life sciences venture, are pleased to announce a new partnership between these leading innovation organizations.
READ MORE
|
|
 |
Farabloc Development Corporation is a private company headquartered in Coquitlam, British Columbia. Their corporate mission is to develop Farabloc as a mainstream international fitness and rehabilitation product that can be used to reduce pain and to assist in healing.
|
|
|
|
Libang Surgical Technologies (LST), based in Vancouver, is developing a next-generation surgical robot. LST is backed by Libang Capital, part of one of China’s largest pharmaceutical manufacturers, Libang.
|
|
|
|
Community - Sector Interest
|
|
|
|
Seeking input for BC COVID-19 Strategic Research Framework
|
1) Enabling Rapid Research Response
There are a variety of structures in place to facilitate research including expedited ethics processes and rapid data access.
2) Research Priorities
Work is under way to better understand the impact of COVID-19 and its control measures.
3) Knowledge Translation
What additional processes/approaches should be introduced to facilitate the production and use of research findings by decision-makers? By the public?
4) Additional Feedback
Are there any other considerations you would like to see included in the strategic research framework?
|
|
|
|
Korea Virtual Trade Mission – Asia Procurement Opportunities
|
Upcoming Virtual Trade Missions in ASIA Coordinated by Global Affairs Canada
- KOREA: Virtual Trade Mission to Seoul
- Inter-American Development Bank (IDB)
- Follow-up to international procurement opportunity from the World Bank/Asian Development Bank
|
|
|
|
Vancouver-based study to help quickly diagnose patients most at risk of dying from COVID-19
|
Researchers based in Vancouver are working to save the lives of critical care patients with COVID-19.
VANCOUVER (NEWS 1130) — It’s not a cure, but hope for life-saving treatment. That’s what a team of researchers at the University of British Columbia is working on to help critical care patients during the pandemic.The goal is to quickly diagnose people more likely to develop severe sepsis.
READ MORE
|
|
|
|
Update: Student Work Placement Program now open to healthcare placements
|
The Student Work Placement Program is now accepting applications for healthcare placements. Canada’s healthcare industry has a growing need to produce job-ready healthcare workers. There are 1,500 open spots available in 2020-21.
WEBSITE
|
|
|
|
Posting A JOB on the LSBC Website
|
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's
The Petri Dish
After your first five reposts, you will also receive 25% off all job postings on
The Petri Dish
. Want more info?
CONTACT: Sue Callaghan -
talent@lifesciencesbc.ca
|
|
|
|
Membership Benefits Program
COST SAVINGS FOR OUR MEMBERS
As a LifeSciences BC member, organizations and their employees can benefit from significant savings on a range of business and personal services, thanks to our Membership Benefits Program partnerships. You can locate the cost savings program suited to you needs
here
.
|
|
|
|
|
|
|
